News Releases & Statements
News Releases & Statements
New Drug Approval Expands Treatment Options for Patients with Marginal Zone Lymphoma
Posted On: September 17, 2021Rye Brook, N.Y., September 17, 2021 - The U.S. Read More
LLS Encouraged by Progress in Congress on Policies That Support Patients
Posted On: September 17, 2021Rye Brook, N.Y., Sept. 17, 2021—The Leukemia & Lymphoma Society thanks members of the House Energy & Commerce Committee and the House Ways & Means Committee who voted to take critical steps to reduce barriers to care and increase affordability for many of the nearly 1.5 million people in the U.S. living with blood cancer. These crucial reforms will ensure more people can get the treatment they need at the moment they need it.
Read More
FDA Approves New Treatment Option for Rare Form of Lymphoma
Posted On: September 14, 2021Rye Brook, N.Y., September 14, 2021 - The U.S. Food and Drug Administration (FDA) recently approved zanubrutinib (Brukinsa®) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM). This is the second therapy approved specifically for the treatment of this rare type of lymphoma. Zanubrutinib is a next-generation BTK inhibitor, which is designed to provide more targeted treatment with improved tolerability.
Read More
LLS Statement on Federal Vaccination Strategy
Posted On: September 10, 2021(Rye Brook, NY, Sept. 10, 2021) — Our top priority is — and always has been — the safety of blood cancer patients and survivors. We know that they are at increased risk of serious illness and death from COVID-19. However, up to 1 in 4 blood cancer patients won’t produce COVID-19 antibodies after vaccination, making it even more important for those around them to be vaccinated.
Read More
New Study Shows Most Blood Cancer Patients Benefit from an Additional COVID-19 Vaccine Dose
Posted On: September 10, 2021Immune suppressing treatments - an essential component of many patient's cancer care - can blunt vaccine immune response
Read More
The Leukemia & Lymphoma Society (LLS) Named Charitable Partner of Largest Esports League in North America
Posted On: September 9, 2021 Read More
Every 180 Seconds, Someone in the U.S. is Diagnosed with a Blood Cancer; it’s Time to Make an Impact Together
Posted On: September 1, 2021(Rye Brook, NY, Sept. 1, 2021) — September is Blood Cancer Awareness Month, an opportunity to remind the public that every 180 seconds, someone in the U.S. has their life turned upside down by a blood cancer diagnosis. Read More
New COVID-19 Staff Safety Policies at LLS
Posted On: August 16, 2021The following memo from Louis J. DeGennaro, Ph.D., President and Chief Executive Officer of The Leukemia & Lymphoma Society (LLS), was shared with LLS staff on Tuesday, 8/17. The email has been edited to remove internal links.
Read MoreMedia Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org. An LLS representative will respond as soon as possible.